DNCA Invest Value Europe Class N EURRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31/10/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | -10,9 | 19,2 | -1,0 | 13,5 | 13,1 | |
+/-Cat | -3,2 | -3,6 | 6,9 | -1,6 | 5,5 | |
+/-Idx | - | - | - | -2,4 | 4,1 | |
Categorie: Aandelen Europa Large-Cap Waarde | ||||||
Benchmark: Morningstar Dev Europe Val ... |
Kerngegevens | ||
Koers 21/11/2024 | EUR 131,72 | |
Rendement 1 Dag | 0,45% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Waarde | |
ISIN | LU1234713698 | |
Grootte Fonds (Mil) 21/11/2024 | EUR 570,84 | |
Grootte Fondsklasse (Mil) 21/11/2024 | EUR 1,26 | |
Aankoopkosten (Max) | 2,00% | |
Lopende Kosten Factor 05/08/2024 | 1,42% | |
Gesloten voor nieuwe beleggers | nee |
Beleggingsdoelstelling: DNCA Invest Value Europe Class N EUR |
The Sub-Fund seeks to outperform the following Index: STOXX EUROPE 600 Index Net Return (Bloomberg ticker: SXXR Index), over the recommended investment term. Investors’ attention is drawn by the fact that the management style is discretionary and integrates environmental, social / societal and governance (ESG) criteria. The Sub-Fund will at all times invest at least two-thirds of its total assets in equities of issuers having their registered office in Europe or exercising the preponderant part of their economic activities in Europe (hereinafter "European Equities"). |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Isaac Chebar 21/12/2007 | ||
Maxime Genevois 04/08/2015 | ||
Click here to see others | ||
Oprichtingsdatum 10/10/2017 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
STOXX Europe 600 NR EUR | Morningstar Dev Europe Val TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? DNCA Invest Value Europe Class N EUR | 31/10/2024 |
|
|
Top 5 posities | Sector | % |
ISS AS | Industrie | 2,92 |
Anglo American PLC | Grondstoffen | 2,86 |
ASR Nederland NV | Financiële Dienstverlening | 2,77 |
Enel SpA | Nutsbedrijven | 2,70 |
Sanofi SA | Gezondheidszorg | 2,65 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
DNCA Invest Value Europe Class N EUR |